Nxera Pharma Co (TSE:4565) Total Liabilities : 円82,980 Mil (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Nxera Pharma Co Total Liabilities?

Nxera Pharma Co's Total Liabilities for the quarter that ended in Dec. 2024 was 円82,980 Mil.

Nxera Pharma Co's quarterly Total Liabilities declined from Jun. 2024 (円87,504.00 Mil) to Sep. 2024 (円84,578.00 Mil) and declined from Sep. 2024 (円84,578.00 Mil) to Dec. 2024 (円82,980.00 Mil).

Nxera Pharma Co's annual Total Liabilities increased from Dec. 2022 (円41,481.00 Mil) to Dec. 2023 (円90,388.00 Mil) but then declined from Dec. 2023 (円90,388.00 Mil) to Dec. 2024 (円82,980.00 Mil).

Nxera Pharma Co Total Liabilities Historical Data

The historical data trend for Nxera Pharma Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Total Liabilities Chart

Nxera Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

24,084.00

39,517.00

41,481.00

90,388.00

82,980.00

Nxera Pharma Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															90,388.00	86,405.00	87,504.00	84,578.00	82,980.00

Nxera Pharma Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nxera Pharma Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15632	+	(61210	+	6138
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	82,980

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	151498	-	68518
	=	82,980

Nxera Pharma Co's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15632	+	(61210	+	6138
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	82,980

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	151498	-	68518
	=	82,980

Nxera Pharma Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (TSE:4565) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

SOLTF:USA

Address

Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052

Website

https://www.nxera.life

Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

Nxera Pharma Co Headlines

No Headlines